Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11464784
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
granted -
US 11464886
Controllable self-annealing microgel particles for biomedical applications
granted -
US 11458107
Abiotic anti-VEGF nanoparticle
granted -
US 11459385
Anti-IL-2 antibodies and compositions and uses thereof
granted -
US 11452780
Mtorc1 inhibitors
granted -
US 11453891
Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9
granted -
US 11447563
Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
granted -
US 11446253
Ionic liquids for internal delivery
granted -
US 11446279
Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof
granted -
US 11447508
Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
granted -
US 11439615
Lipoxin and lipoxin analogue mediated neuroprotection and treatments
granted -
US 11439659
Methods and compositions to prevent and treat inflammation and allergic reactions
granted -
US 11439695
Kidney injury treatment
granted -
US 11439611
Administration of serine protease inhibitors to the stomach
granted -
US 11439708
Nanotube trans-membrane channels mimicking biological porins
granted -
US 11433118
Long-acting VEGF inhibitors for intraocular neovascularization
granted -
US 11434267
Peptides having reduced toxicity that stimulate cholesterol efflux
granted -
US 11434301
Anti-CD46 antibodies and methods of use
granted -
US 11435349
CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs
granted -
US 11433143
Nano-enabled immunotherapy in cancer
granted -
US 11435366
Noninvasive method to quantify kidney function and functional decline
granted -
US 11427588
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
granted -
US 11422132
Peptides and uses thereof for diagnosing and treating myasthenia gravis
granted -
US 11419883
Inhibiting senescent processes in beta cells for the prevention of type 1 diabetes
granted